Latest filing published 25 Aug 2022 for Rani Therapeutics Holdings, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Andrew Farquharson: trading record in brief
All filings by Andrew Farquharson on record concern Rani Therapeutics Holdings, Inc., in the capacity of board member. Between 3 February 2022 and 23 August 2022, the trades on record add up to 9 filings.
Every open-market trade on record is a sale: 2 sales worth €839k.
The latest filing, published on 25 August 2022, reports a transaction in Rani Therapeutics Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew Farquharson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,694 shares0Class B Common StockSEC:0001209191-22-047662:0
- 71,042 shares@ US$10.51100.0% of flowClass A Common StockSEC:0001209191-22-046957:0
- 2,309,490 shares0Class B Common StockSEC:0001179110-22-002127:0
- 827,467 shares0Class A Common StockSEC:0001209191-22-007637:0
4 of 4 declarations